HeidaryZKhaliliHMohammadiMBeigmohammadiMTAbdollahiA. Effect of magnesium loading dose on insulin resistance in patients with stress-induced hyperglycemia: a randomized clinical trial. J Intensive Care Med. 2018. doi:885066618777431.
2.
GröberUSchmidtJKistersK. Magnesium in prevention and therapy. Nutrients. 2015;7(9):8199–8226.
3.
BarbagalloMDominguezLJ. Magnesium and type 2 diabetes. World J Diabetes. 2015;6(10):1152–1157.
4.
WallaceTMLevyJCMatthewsDR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487–1495.
5.
MatherKJHuntAESteinbergHO, et al.Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab. 2001;86(11):5457–5464.
6.
LotzTFChaseJGMcAuleyKA, et al.Monte Carlo analysis of a new model-based method for insulin sensitivity testing. Comput Methods Programs Biomed. 2008;89(3):215–225.
7.
PoonAKMeyerMLReavenG, et al.Short-term repeatability of insulin resistance indexes in older adults: the atherosclerosis risk in communities study. J Clin Endocrinol Metab. 2018;103(6):2175–2181.
8.
CroftsCAPWheldonMCZinnC, et al.Assessing the test–retest repeatability of insulin resistance measures: homeostasis model assessment 2 and oral glucose insulin sensitivity. J Insulin Resistance. 2017:2(1):a27.
9.
MatteucciEGiampietroOCovolanVGiustariniDFantiPRossiR. Insulin administration: present strategies and future directions for a noninvasive (possibly more physiological) delivery. Drug Des Devel Ther. 2015;9:3109–3118.
10.
LescotTKarvellasCBeaussierMMagderS. Acquired liver injury in the intensive care unit. Anesthesiology. 2012;117(4):898–904.
11.
MarikPERaghavanM. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med. 2004;30(5):748–756.
12.
WeickertMOLoeffelholzCVRodenM, et al.A Thr94Ala mutation in human liver fatty acid-binding protein contributes to reduced hepatic glycogenolysis and blunted elevation of plasma glucose levels in lipid-exposed subjects. Am J Physiol Endocrinol Metab. 2007;293(4):E1078–E1084.
